Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON24610Active, not recruiting
Randomised, open-label trial in seizure and hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by EpilepsieNL. Primary endpoints: Number of electrographic seizure discharges missed without continuous monitoring, Reduction of seizure discharges with immediate treatment of electrographic seizures and 1 more. Started Jul 2003; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON24610.